First-in-Class Potential! FDA Clears IND Application for LBL-047, an Anti-BDCA2/TACI Bispecific Fusion Protein Developed by Leads Biolabs ...Middle East

NANJING, China, Sept. 22, 2025 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company", Stock Code: 9887.HK) announced that the U.S. Food and Drug Administration (FDA) has approved its first-in-human Investigational New Drug (IND) application for LBL-047 on...

Hence then, the article about first in class potential fda clears ind application for lbl 047 an anti bdca2 taci bispecific fusion protein developed by leads biolabs was published today ( Monday 22/09/2025 - 07:21 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( First-in-Class Potential! FDA Clears IND Application for LBL-047, an Anti-BDCA2/TACI Bispecific Fusion Protein Developed by Leads Biolabs )

Also on site :

• 1985 Hit Novel, Written By a 21-Year-Old, Was Inspired By an Elvis Costello Song
• Rochester man accused of raping 15 year old who State Police say he met online
• Netflix's 'The Idaho Murders: College Nightmare' Reveals These 10 Disturbing Details About the Bryan Kohberger Case